Botvynko Alina, Synytsya Andriy, Čurda Ladislav
Department of Dairy, Fat and Cosmetics, University of Chemistry and Technology in Prague, Technická 5, 166 28, Prague, Czech Republic.
Department of Carbohydrates and Cereals, University of Chemistry and Technology in Prague, Technická 5, 166 28, Prague, Czech Republic.
Biochem Biophys Res Commun. 2025 Jan;744:151204. doi: 10.1016/j.bbrc.2024.151204. Epub 2024 Dec 18.
Galactooligosaccharides (GOS) are lactose-derived functional ingredients applied in food products and have great potential in health protection. The conversion of lactose to GOS commonly occurs using β-galactosidases of mould, yeast and bacterial origin. The yield and structure of the resulting GOS depend on the enzyme used and the reaction conditions. This work focuses on the structural analysis of the products obtained with four commercial β-galactosidases Maxilact LGI 5000 (ML), Maxilact A4 MG (MA), Saphera 2600 L (SA) and NOLA Fit 5500 (NL) to evaluate their efficiency and specificity. HPLC, ESI-MS and NMR spectroscopy were applied to characterise the GOS preparations. GOS were separated from the reaction mixture using activated charcoal treatment. HPLC analysis confirmed that most of the monosaccharides and a part of the lactose, but also some other disaccharides, probably allolactose and 6-galactobiose, were retained by charcoal. In all the products, ESI-MS analysis detects oligosaccharides up to hexamers. NMR spectra confirmed the presence of GOS of various configurations and polymerisation degrees and evaluated the specificity of used enzymes. MA preferably forms 1,6- and 1,4-glycosidic bonds, and bacterial enzymes NL and SA also form 1,2- and 1,3- glycosidic bonds, while yeast enzyme ML cannot produce new 1,4-glycosidic bonds. The mould enzyme MA showed the highest trans-galactosylation activity, forming longer GOS oligomers than the other enzymes.
低聚半乳糖(GOS)是源自乳糖的功能性成分,应用于食品中,在健康保护方面具有巨大潜力。乳糖向GOS的转化通常使用霉菌、酵母和细菌来源的β-半乳糖苷酶来实现。所得GOS的产量和结构取决于所使用的酶和反应条件。这项工作着重于对用四种商业β-半乳糖苷酶Maxilact LGI 5000(ML)、Maxilact A4 MG(MA)、Saphera 2600 L(SA)和NOLA Fit 5500(NL)获得的产物进行结构分析,以评估它们的效率和特异性。采用高效液相色谱(HPLC)、电喷雾电离质谱(ESI-MS)和核磁共振光谱(NMR)对GOS制剂进行表征。通过活性炭处理从反应混合物中分离出GOS。HPLC分析证实,大部分单糖和一部分乳糖,还有一些其他二糖,可能是别乳糖和6-半乳糖二糖,被活性炭保留。在所有产物中,ESI-MS分析检测到了直至六聚体的寡糖。NMR光谱证实了存在各种构型和聚合度的GOS,并评估了所用酶的特异性。MA优先形成1,6-和1,4-糖苷键,细菌酶NL和SA还形成1,2-和1,3-糖苷键,而酵母酶ML不能产生新的1,4-糖苷键。霉菌酶MA表现出最高的转半乳糖基化活性,形成的GOS寡聚物比其他酶形成的更长。